Aire Advisors, LLC Pfizer Inc Transaction History

Aire Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $84,293 - $110,035	-2,019 Reduced 24.06%	6,373 $326,000
Q3 2022 Oct 28, 2022	SELL	$43.76 - $53.42 $69,753 - $85,151	-1,594 Reduced 15.96%	8,392 $367,000
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $126,933 - $150,503	2,728 Added 37.59%	9,986 $528,000
Q1 2022 May 06, 2022	BUY	$45.75 - $56.69 $41,861 - $51,871	915 Added 14.43%	7,258 $376,000
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $262,092 - $388,508	6,343 New	6,343 $375,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Aire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Aire Advisors, LLC with notifications on news.